Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus
NCT05806502 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-06-21
Summary
To evaluate the efficacy of arginase inhibition on endothelial function in patients with type 1 diabetes and type 2 diabetes.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Nω-hydroxy-nor-arginine
Arginase inhibitor
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John Pernow, MD · Karolinska Institutet
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2023-04-30
- Completion
- 2023-04-30
Countries
- Sweden
Study Locations
More Related Trials
-
Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus
NCT03318913 ·Status: COMPLETED ·Phase: NA
-
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
NCT00520962 ·Status: COMPLETED
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Arterial Composition and Cardiovascular Outcome in DIabeteS
NCT04150315 ·Status: UNKNOWN
-
Mechanisms of Endothelial Dysfunction in Type 2 Diabetes
NCT02311075 ·Status: COMPLETED ·Phase: NA
-
Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes
NCT05068895 ·Status: UNKNOWN
-
Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes
NCT03480945 ·Status: COMPLETED
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2
NCT00638209 ·Status: UNKNOWN ·Phase: NA
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT04971252 ·Status: COMPLETED
-
Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications
NCT07250607 ·Status: ACTIVE_NOT_RECRUITING
-
Type 2 Diabetes Mellitus and Atherosclerosis
NCT01250340 ·Status: UNKNOWN ·Phase: PHASE4
-
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NCT05369065 ·Status: RECRUITING ·Phase: PHASE1
-
Prognosis of Type 2 Diabetic Patients
NCT01426685 ·Status: UNKNOWN
-
The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
NCT00850798 ·Status: UNKNOWN ·Phase: NA
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
NCT03824002 ·Status: COMPLETED ·Phase: PHASE4
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
Risk Prediction in Type II Diabetics With Ischemic Heart Disease
NCT01422057 ·Status: UNKNOWN
-
Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis
NCT01016509 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes
NCT06224803 ·Status: COMPLETED ·Phase: NA
-
Metabolomic Profiling of Novel Mediators of Vascular Function
NCT00762242 ·Status: TERMINATED
-
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
NCT00762671 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes
NCT00256607 ·Status: COMPLETED